Atrial fibrillation is the most common sustained cardiac arrhythmia, affecting over 1.4 million people in the UK alone.
Left untreated, AF puts patients at significant risk of stroke – a leading cause of disability that costs the NHS and wider economy billions each year.
We speak with Dr Angelo Auricchio of Boston Scientific about Pulsed Field Ablation (PFA) – an innovative treatment that could help reduce waiting lists while also addressing the associated risks of stroke and heart failure.
Listen now on Spotify:
